Omeprazole Zentiva Pharma (Omeprazole Sodium)

Omeprazole, the active ingredient in Omeprazole Zentiva Pharma, is a proton pump inhibitor presented as a intravenous solution for IV use. It reduces gastric acid secretion and is used in the management of acid‑related gastrointestinal conditions in adults. GNH USA supplies Omeprazole Zentiva Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

GNH USA supplies Omeprazole Zentiva Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Omeprazole Zentiva Pharma is a proton pump inhibitor that acts on gastric acid secretion pathways. It is indicated for several clinical conditions: - Peptic ulcer disease: promotes healing of gastric and duodenal ulcers. - Gastro‑oesophageal reflux disease (GERD): reduces reflux symptoms and promotes mucosal healing. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with gastrin‑secreting tumors. - Prevention of stress‑induced ulceration in critically ​  ​ ​  ​ hospitalised   ​  ​patients. - Use  ​ ​ ​ ​in  ​  ​ ​ ​ ​post‑  ​ ​​post ​ ​ ​surgery ​ ​recovery ​ ​to ​ ​prevent ​ ​​ulcers ​​ ​.